Seungil Kim

The paper introduces SCOPE, a method using AI and time-lapse imaging to classify drug responses in organoids into four phenotypic groups, identifying new drug effects and therapeutic uses.

The paper integrates computational metabolic modeling with experimental validation to identify hexokinase as a therapeutic target in colorectal cancer by analyzing CAF-conditioned tumor organoids.

This study evaluates a hydrogel with porosity and extracellular matrix digest in a rat myocardial infarction model, showing improved cardiac function and neovascularization compared to other hydrogels and PBS.